Revenue
5.84 million USD
2020 Q2 · USD
Exact inputs and evidence
- Revenue: 5840208 USD Source
Fundies. English
Positive Physicians Holdings, Inc.
EDGAR9 filing records in this dataset, filed from 2019-01-22 to 2020-08-14. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 22.9 million USD Source
Exact value
22867591 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 3.62 million shares Source
Exact value
3615500 shares
Reported share-count change
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
24.1 million USD
2019-07-01 – 2020-06-30
Net income
-534 thousand USD
2019-07-01 – 2020-06-30
Exact inputs and evidence
Operating cash flow
-236 thousand USD
2019-07-01 – 2020-06-30
Exact inputs and evidence
- Operating cash flow: -14236706 USD · 2019-01-01 – 2019-09-30 Source
- Operating cash flow: -14367325 USD · 2019-01-01 – 2019-06-30 Source
- Operating cash flow: -13352352 USD · 2019-01-01 – 2019-12-31 Source
- Operating cash flow: -14236706 USD · 2019-01-01 – 2019-09-30 Source
- Operating cash flow: 147745 USD · 2020-01-01 – 2020-03-31 Source
- Operating cash flow: -1251338 USD · 2020-01-01 – 2020-06-30 Source
- Operating cash flow: 147745 USD · 2020-01-01 – 2020-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2020-08-14.
Financial data available through: 2019-12-31.
Coverage by financial measure
- Revenue: 2 of 11 periods available· newest 2019-12-31
- operating income: No compatible figures in this window
- Net income: 2 of 11 periods available· newest 2019-12-31
- Operating cash flow: 2 of 11 periods available· newest 2019-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 2 of 11 periods available· newest 2019-12-31
- Total liabilities: 2 of 11 periods available· newest 2019-12-31
- current assets: No compatible figures in this window
- current liabilities: No compatible figures in this window
- Cash and cash equivalents: 2 of 11 periods available· newest 2019-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2019-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+13.6%Prior period
USD 24.62 million
–
Current period
USD 27.97 million
–
Exact inputs and evidence
27965606 − 24623479 = 3342127 USD
24623479 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source27965606 USD · 2019-01-01 – 2019-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 5.13 millionPrior period
−USD 5.37 million
–
Current period
−USD 238,951
–
Exact inputs and evidence
-238951 − -5371516 = 5132565 USD
-5371516 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source-238951 USD · 2019-01-01 – 2019-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 6.59 millionPrior period
−USD 6.77 million
–
Current period
−USD 13.35 million
–
Exact inputs and evidence
-13352352 − -6765867 = -6586485 USD
-6765867 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source-13352352 USD · 2019-01-01 – 2019-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2019 2019-01-01 – 2019-12-31
- Revenue USD 27.97 million 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income −USD 238,951 −0.9% of revenue
Cash
- Operating cash flow −USD 13.35 million −48% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2018 Not shown: operating income or net income is not reported.
- 2019 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | 24623479 | Unavailable | Unavailable | Unavailable | -5371516 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 27965606 | Unavailable | Unavailable | Unavailable | -238951 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 28M 2019
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 24623479 |
|
| 2019 | Revenue | 27965606 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
13.6% 2019
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | 13.6% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Net margin -0.9% 2019
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018-12-31 | Operating margin | Not reported |
|
| 2019-12-31 | Operating margin | Not reported |
|
| 2018 | Net margin | -21.8% |
|
| 2019 | Net margin | -0.9% |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -13.4M 2019
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -6765867 |
|
| 2019 | Operating cash flow | -13352352 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
53.3% 2019
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Liabilities / assets | 70.2% |
|
| 2019 | Liabilities / assets | 53.3% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2019-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | −USD 5.37 million Exact valueExact value: -5371516 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.77 million Exact valueExact value: -6765867 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 238,951 Exact valueExact value: -238951 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.35 million Exact valueExact value: -13352352 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
9 filings · 392 latest values · 392 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001752039, 1752039, PPHI, edgar:1752039
Also known as POSITIVE PHYSICIANS HOLDINGS, INC., POSITIVE PHYSICIANS HOLDINGS,INC., Positive Physicians Holdings, Inc.